Blog Archives

COVID-19 vaccine development part 26

Posted in Tak Berkategori | Leave a comment

COVID-19 vaccine development part 25

Posted in Tak Berkategori | Leave a comment

COVID-19 vaccine development part 24

Posted in Tak Berkategori | Leave a comment

COVID-19 vaccine development part 23

Posted in Tak Berkategori | Leave a comment

COVID-19 vaccine development part 22

Posted in Tak Berkategori | Leave a comment

COVID-19 vaccine development part 21

Resources on COVID-19 vaccines development: WHO target product profile for COVID-19 vaccine Vaccine landscape Solidarity vaccine trial Access to COVID tools (ACT) Accelerator COVAX facility (WHO) Covax explained (GAVI) COPVAX (CEPI) WHO guidance on ethnics of vaccine allocation

Posted in Tak Berkategori | Leave a comment

COVID-19 vaccine development part 20

Working together to deliver vaccine to all countries: The Access to Covid-19 Tools (ACT) Accelerator was launched in April 2020 to speed up development and delivery to countries of diagnostics, treatments and vaccines. It includes a health systems connector to … Continue reading

Posted in Tak Berkategori | Leave a comment

COVID-19 vaccine development part 19

WHO Solidarity vaccine trial (Achieving rapid progress towards global objectives) : Evaluating several different candidate vaccines:       Increasing the likelihood of finding several effective vaccines Expenditiously enrolling people at sites with high rates of COVID-19:       … Continue reading

Posted in Tak Berkategori | Leave a comment

COVID-19 vaccine development part 9

Immunogens used to develop viral vaccines : Replicating or non-replicating viral vector : Viral pathogen expressed on a safe virus that doesn’t cause  disease Rapid development Prior exposure to vector virus (eg. adenovirus) may reduce immunogenicity Example of vaccines : … Continue reading

Posted in Tak Berkategori | Leave a comment

COVID-19 vaccine development part 8

Immunogens used to develop viral vaccines Peptides : Synthetic produced fragment of an antigen Rapid development Poorly immunogenic; high cost Example of vaccines : COVID-19 vaccines in development

Posted in Tak Berkategori | Leave a comment